Millennium Investment & Acquisition Company Inc (MILC) Fair Value & Analysis
Healthcare · US · Market cap $2.2K
Millennium Investment & Acquisition Company Inc
MILC · US
Fair value as of: Jul 29, 2026
From 1 valuation models · updated 20 days ago
Fair value updated Jul 29, 2026, revised from $0.0002 to $0.0004 (+100.0%) since Jun 26, 2026. Share price −50.0% over the past month.
Below-average quality, screening 100% undervalued on our models.
What matters now
- The large discount to fair value meets weak quality (33/100). That raises the risk this is a value trap rather than a bargain.
- The price is below even our cautious bear case ($0.0004). The market is more pessimistic than our downside scenario.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 29, 2026.
How to read this chart
60‑month range $0.0001 – $10.15 · the $0.0002 price screens below the $0.0004 fair value. Dashed = 300-day average. As of Jul 29, 2026.
Analysis
Millennium Investment & Acquisition Company Inc (MILC) currently trades at $0.0002, while our model-based Fair Value estimate is $0.0004, implying the stock looks roughly 100.0% undervalued today. The Quality Score stands at 33/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.
Trailing-twelve-month revenue stands at $170K. Net debt stands at $40.7M. Fundamentals as of Jul 29, 2026
The share trades about 33% below its 52-week high and 100% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -49% fair-value upside, at 100%, MILC screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when MILC reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 29, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 33 · Market factors (momentum, volatility) 62
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Millennium Investment and Acquisition Co. Inc. (ticker: MILC) MILC has three assets: 1) Activated Carbon ("AC") plant located in Kawaihae, Hawaii 2) SMC Global ("SMC") - India financial services firm 3) Approximately $2 million of cash and short term investments (zero debt) Investors in MILC can gain exposure to Alternative Energy and India which are …
Full company description
Millennium Investment and Acquisition Co. Inc. (ticker: MILC) MILC has three assets: 1) Activated Carbon ("AC") plant located in Kawaihae, Hawaii 2) SMC Global ("SMC") - India financial services firm 3) Approximately $2 million of cash and short term investments (zero debt) Investors in MILC can gain exposure to Alternative Energy and India which are two potentially appealing investment allocation sectors.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2017 – FY2021 · reported fiscal years
Millennium Investment & Acquisition Company Inc reported revenue of $41.8K in FY2021 versus $8.5M in FY2017, a compound −73.5%/yr. Reported net income was −$7.2M in FY2021.
Watch MILC: get an alert when its fair value changes →
Peer Group
Drug Manufacturers - Specialty & Generic · 625 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jul 29, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥53.76 | ¥25.94 | -52% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,944 | ₹989.50 | -49% |
| Divi's Laboratories Limited DIVISLAB | ₹8,500 | ₹1,932 | -77% |
| Torrent Pharmaceuticals Limited TORNTPHARM | ₹4,915 | ₹1,163 | -76% |
| PharmaEssentia Corporation 6446 | 1,440 TWD | 233.93 TWD | -84% |
| Cipla Limited CIPLA | ₹1,463 | ₹1,001 | -32% |
| Zydus Lifesciences Limited ZYDUSLIFE | ₹1,167 | ₹703.32 | -40% |
| Lupin Limited LUPIN | ₹2,281 | ₹2,477 | +9% |
| Mankind Pharma Limited MANKIND | ₹2,433 | ₹983.11 | -60% |
| Dr. Reddy's Laboratories Limited DRREDDY | ₹1,200 | ₹874.79 | -27% |
Compare Millennium Investment & Acquisition Company Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Millennium Investment & Acquisition Company Inc (MILC) overvalued or undervalued?
What is the fair value of MILC?
What is the quality score of MILC?
What is the revenue of Millennium Investment & Acquisition Company Inc (MILC)?
What is the net profit margin of MILC?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Millennium Investment & Acquisition Company Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.